165 related articles for article (PubMed ID: 21296518)
1. Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.
Jin GY; Bok SM; Han YM; Chung MJ; Yoon KH; Kim SR; Lee YC
Eur J Radiol; 2012 Aug; 81(8):1901-6. PubMed ID: 21296518
[TBL] [Abstract][Full Text] [Related]
2. Serial micro-CT assessment of the therapeutic effects of rosiglitazone in a bleomycin-induced lung fibrosis mouse model.
Choi EJ; Jin GY; Bok SM; Han YM; Lee YS; Jung MJ; Kwon KS
Korean J Radiol; 2014; 15(4):448-55. PubMed ID: 25053904
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.
Lee HJ; Goo JM; Kim NR; Kim MA; Chung DH; Son KR; Kim HC; Lee CH; Park CM; Chun EJ; Im JG
Invest Radiol; 2008 Jun; 43(6):453-60. PubMed ID: 18496052
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats.
Samah M; El-Aidy Ael-R; Tawfik MK; Ewais MM
Eur J Pharmacol; 2012 Aug; 689(1-3):186-93. PubMed ID: 22659583
[TBL] [Abstract][Full Text] [Related]
5. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography.
Cavanaugh D; Travis EL; Price RE; Gladish G; White RA; Wang M; Cody DD
Acad Radiol; 2006 Dec; 13(12):1505-12. PubMed ID: 17138119
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of bleomycin-induced lung fibrosis in rabbits using sequential in vivo regional analysis and high-resolution computed tomography: correlation with pathologic findings.
Nagatani Y; Nitta N; Otani H; Mukaisho K; Sonoda A; Nitta-Seko A; Takahashi M; Murata K
Acad Radiol; 2011 Jun; 18(6):672-81. PubMed ID: 21393029
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
8. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
[TBL] [Abstract][Full Text] [Related]
9. A micro-computed tomography-based method for the measurement of pulmonary compliance in healthy and bleomycin-exposed mice.
Shofer S; Badea C; Auerbach S; Schwartz DA; Johnson GA
Exp Lung Res; 2007; 33(3-4):169-83. PubMed ID: 17558678
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
Genovese T; Cuzzocrea S; Di Paola R; Mazzon E; Mastruzzo C; Catalano P; Sortino M; Crimi N; Caputi AP; Thiemermann C; Vancheri C
Eur Respir J; 2005 Feb; 25(2):225-34. PubMed ID: 15684285
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin-induced fibrosis in pigs: evaluation with CT.
Balazs G; Noma S; Khan A; Eacobacci T; Herman PG
Radiology; 1994 Apr; 191(1):269-72. PubMed ID: 7510895
[TBL] [Abstract][Full Text] [Related]
12. Correlation between high resolution computed tomography and tissue morphometry of the lung in bleomycin-induced pulmonary fibrosis in the rabbit.
Hirose N; Lynch DA; Cherniack RM; Doherty DE
Am Rev Respir Dis; 1993 Mar; 147(3):730-8. PubMed ID: 7680190
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Vande Velde G; Poelmans J; De Langhe E; Hillen A; Vanoirbeek J; Himmelreich U; Lories RJ
Dis Model Mech; 2016 Jan; 9(1):91-8. PubMed ID: 26563390
[TBL] [Abstract][Full Text] [Related]
15. Imaging techniques for small animal imaging models of pulmonary disease: micro-CT.
Johnson KA
Toxicol Pathol; 2007 Jan; 35(1):59-64. PubMed ID: 17325973
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ; Hayes B; Alexander R; Datta A; Forty EJ; Mercer PF; Blanchard A; Chambers RC
Eur Respir J; 2013 Dec; 42(6):1633-45. PubMed ID: 23520313
[TBL] [Abstract][Full Text] [Related]
17. In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach.
Mecozzi L; Mambrini M; Ruscitti F; Ferrini E; Ciccimarra R; Ravanetti F; Sverzellati N; Silva M; Ruffini L; Belenkov S; Civelli M; Villetti G; Stellari FF
Sci Rep; 2020 Oct; 10(1):18735. PubMed ID: 33127949
[TBL] [Abstract][Full Text] [Related]
18. A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.
Ruscitti F; Ravanetti F; Donofrio G; Ridwan Y; van Heijningen P; Essers J; Villetti G; Cacchioli A; Vos W; Stellari FF
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708527
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib attenuates murine pulmonary fibrosis induced by bleomycin.
Wang P; Tian Q; Liang ZX; Yang Z; Xu SF; Sun JP; Chen LA
Chin Med J (Engl); 2010 Aug; 123(16):2259-64. PubMed ID: 20819676
[TBL] [Abstract][Full Text] [Related]
20. Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1.
Rodt T; von Falck C; Dettmer S; Halter R; Maus R; Ask K; Kolb M; Gauldie J; Länger F; Hoy L; Welte T; Galanski M; Maus UA; Borlak J
Respir Res; 2010 Dec; 11(1):181. PubMed ID: 21176193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
